Not bad. First of all, talk about the strength of this company. It has rich R&D experience in chemical raw materials and other businesses, and also conducts business at home and abroad. Its products are listed and sold in thousands of overseas medical institutions.
Second, talk about revenue. According to the prospectus disclosed by the company, the operating income has achieved steady growth in the past three years, and the revenue scale in 2020 has exceeded 654.38+03 billion yuan.